Yousif Capital Management LLC Decreases Stock Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)

Yousif Capital Management LLC lessened its position in Takeda Pharmaceutical Company Limited (NYSE:TAK) by 1.6% during the 4th quarter, HoldingsChannel.com reports. The fund owned 48,119 shares of the company’s stock after selling 792 shares during the quarter. Yousif Capital Management LLC’s holdings in Takeda Pharmaceutical were worth $637,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in TAK. FMR LLC increased its holdings in shares of Takeda Pharmaceutical by 10.9% in the third quarter. FMR LLC now owns 2,908,918 shares of the company’s stock valued at $41,365,000 after purchasing an additional 286,052 shares during the last quarter. Van ECK Associates Corp increased its holdings in shares of Takeda Pharmaceutical by 6.6% in the third quarter. Van ECK Associates Corp now owns 2,175,236 shares of the company’s stock valued at $30,149,000 after purchasing an additional 134,407 shares during the last quarter. Managed Asset Portfolios LLC increased its holdings in shares of Takeda Pharmaceutical by 0.3% in the third quarter. Managed Asset Portfolios LLC now owns 1,617,541 shares of the company’s stock valued at $23,001,000 after purchasing an additional 4,069 shares during the last quarter. Stifel Financial Corp increased its holdings in shares of Takeda Pharmaceutical by 103.9% in the third quarter. Stifel Financial Corp now owns 440,666 shares of the company’s stock valued at $6,266,000 after purchasing an additional 224,594 shares during the last quarter. Finally, Pathstone Holdings LLC increased its holdings in shares of Takeda Pharmaceutical by 1.0% in the third quarter. Pathstone Holdings LLC now owns 430,676 shares of the company’s stock valued at $6,124,000 after purchasing an additional 4,280 shares during the last quarter. Hedge funds and other institutional investors own 9.17% of the company’s stock.

Takeda Pharmaceutical Price Performance

NYSE:TAK opened at $13.54 on Monday. Takeda Pharmaceutical Company Limited has a one year low of $12.57 and a one year high of $15.08. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.72 and a current ratio of 1.31. The stock has a market cap of $43.07 billion, a PE ratio of 33.84, a P/E/G ratio of 0.24 and a beta of 0.51. The stock has a 50 day moving average price of $13.26 and a 200 day moving average price of $13.88.

Takeda Pharmaceutical (NYSE:TAK) last posted its quarterly earnings results on Thursday, January 30th. The company reported $0.42 EPS for the quarter, beating the consensus estimate of $0.34 by $0.08. Takeda Pharmaceutical had a return on equity of 9.39% and a net margin of 4.53%. Equities research analysts expect that Takeda Pharmaceutical Company Limited will post 1.64 EPS for the current fiscal year.

About Takeda Pharmaceutical

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.